ADAris Dermitzakis

Aris Dermitzakis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aris Dermitzakis has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The WHO methodology framework to assess innovative technologies for low-resource settings

    by Aris Dermitzakis, César Burgi Vieira, Luis Mario Juarez, Einstein Albert Kesi, Sara K. Liaghati-Mobarhan, Debjani Mueller, Nicolas Pallikarakis, Jillian Reichenbach Ott, Daniela Rodríguez Rodríguez, Sasikala Devi Thangavelu, et al.

    Purpose: To present the World Health Organization’s (WHO) multi‑stage methodology used in the 2024 Compendium of Innovative Health Technologies for Low‑Resource Settings and provide a replicable framework for decision‑makers. Methods: Α five‑step process is described covering call preparation, open call and screening, multi‑domain assessment, cross‑checking and final approval, and selection. Evidence‑based assessments were conducted across six areas—clinical need, comparison with WHO technical specifications (MeDevIS), regulatory status (WHO/IMDRF), health technology assessment (HTA), health technology management (HTM), and intellectual property & local production (IP/LP)—using standardized forms and an online innovations assessment database. Evaluations were iterated with feedback from WHO staff and the Strategic Advisory Group on Medical Devices and Health Technologies (STAG MEDEV). Results: In the 2023/24 cycle, 225 submissions were received; 62 technologies underwent full evaluation by multidisciplinary external panels. Following deliberation and validation, 28 technologies were listed (13 commercially available, 3 newly commercialized, 4 prototypes, 1 reassessment, and 7 minor updates), reflecting transparent criteria and consensus‑driven decisions. Conclusions: The WHO methodology operationalizes rigorous, transparent, and context‑appropriate evaluation of health technologies for low‑resource settings. By integrating clinical, regulatory, economic, managerial, and IP/LP perspectives, it supports adoption decisions that balance effectiveness, feasibility, and sustainability. The standardized tools and workflows are readily adaptable by ministries of health and procurement bodies to strengthen technology selection processes.

  • Open Access

    A National Medical Equipment Management System as a Foundation for Post-Market Surveillance

    by Spilios Zisimopoulos, Aris Dermitzakis, Nicolas Pallikarakis

    Voluntary medical device incident reporting to Greece’s national Competent Authority (EOF) remains critically low, undermining post-market surveillance obligations under Regulations (EU) 2017/745 and 2017/746 for medical devices (MDR) and in vitro diagnostics (IVDR). EOF’s voluntary incident reporting mechanism, the “White Card”, received only 35 user submissions nationwide in 2022, revealing a significant gap in the outbound vigilance pathway. This paper presents an architecture for resolving this gap at national scale, through the deployment of the web-Praxis Medical Equipment Management System (MEMS) across all Greek public hospitals and the integration of an upcoming digitized, incident report form developed by EOF. The nationwide MEMS is currently operational across Greek public hospitals, providing a verified national inventory of over 170,000 medical equipment assets and standardized medical equipment management infrastructure. The proposed integration of EOF's digit-ized White Card into web-Praxis is designed to reduce barriers to adverse event reporting through automated device data retrieval and embedded reporting workflows. This paper presents the architecture of this integrated approach and discusses its potential to strengthen post-market surveillance in Greece.

  • Open Access

    Prototyping an Indoor Navigation App with Off-the-Shelf Components to Support Blind and Low-Vision Visitors in a Greek Hospital

    by Damianos Dumi Sigalas, Georgios Papadoulis, Angeliki Kalliampetsou, Emil Valchinov, Christos Sintoris, Aris Dermitzakis


  • ‘3D Printed Breast Phantoms Materials for X-ray Imaging Techniques’

    by Aris Dermitzakis, Martin Pichotka, Antzela Petrai, Moritz Weigt, Nicolas Pallikarakis

  • Feasibility Study for a Robotic Laparoscopic Surgical System in a Greek Public Hospital

    by Spilios Zisimopoulos, Aris Dermitzakis, Anastasia Daskalaki, Mary Marinou, Nicolas Pallikarakis

  • Open Access

    Distribution and Utilisation of Radiotherapy Units in Greece

    by Aris Dermitzakis

    Biomedical Engineering is playing a leading role in the development of medical technology which is one of the pillars of Modern medicine, or as differently expressed at the European Economic and Social Committee (EESC) opinion paper: “Biomedical Engineering is not simply a subset of modern medicine. Modern medicine predominantly secures important advances through the use of the products of biomedical engineering”1. Health technology, according to World Health Organization (WHO), refers to the application of organized knowledge and skills in the form of devices, medicines, vaccines, procedures and systems developed to solve a health problem and improve quality of lives. Therefore, Medical Devices (MDs) belong to the Health Technologies, and Radiotherapy (RT) is an important subgroup of them. Radiotherapy refers to high-tech medical devices that are of high capital value both in terms of initial investment and operation, requiring specially trained personnel for its use and needs regular quality control, preventive maintenance and management procedures, to function properly and safely. Clinical Engineering plays a major role in facing of the afore mentioned challenges. The present paper provides an overview of the results of a study under the WHO action on Strengthening Capacity for Universal Coverage Greece/Phase 2 (SCUC2)2aiming to: Assess the sufficiency and equity in the distribution of RT and its use in Greece Identify eventual inequalities in terms of geographical coverage, specific needs and lack of RT Asses the current status of staffing in RT units Estimate the costs for the use of High Value Capital Medical Equipment (HVCME) Since a country-wide medical equipment inventory for Greece does not exist, various sources were used to obtain a clear picture of the installed units in public Greek hospitals and private clinics. As a result, it came out that, in terms of number of units the per million population the number of RT units rose by 23% from 4.3 in 2009 to 5.3 in 2017. In terms of number of acts, a general increasing trend is noticed, resulting to a total cost increase of 25% from 2013 to 2016. The study revealed that in Greece, there are quite pronounced inequalities in terms of availability of RT technologies in different regions. Long term strategic planning is needed based on evidence, such as updated inventory of MDs, acts performed, associate costs etc , which are unfortunately lacking in Greece. Additionally, the role of clinical engineers in the effective management and safe use of this technology should be widely recognised and regulated.

  • Novel Physical Heterogeneous Breast Phantom for X-Ray Phase Contrast Imaging

    by A. Daskalaki, A. Malliori, A. Dermitzakis, N. Pallikarakis